Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001048477-23-000055 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-12-05 | 2023-12-01 | BMRN | Hardy Alexander | CEO, Dir | A - Grant | $0.00 | +115.4K | 115.4K | New | $0 |
| D | 2023-12-05 | 2023-12-01 | BMRN | Hardy Alexander | CEO, Dir | A - Grant | $0.00 | +150.5K | 150.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-01 | A | A | 68,039 | $0.00 | 68,039 | D | — | — | (F1) Restricted stock units granted on December 1, 2023. Price not applicable. |
| 2 | Common | Common Stock | 2023-12-01 | A | A | 47,332 | $0.00 | 115,371 | D | — | — | (F1) Restricted stock units granted on December 1, 2023. Price not applicable. |
| 3 | Derivative | Stock Option (Right to Buy Common Stock) | 2023-12-01 | A | A | 150,529 | $0.00 | 150,529 | D | $92.42 · 2024-12-01 to 2033-11-30 | 150,529 Common Stock | (F2) Option grant vests 12/48th on December 1, 2024 and 1/48th on the 1st day of each month thereafter. |